Gene therapy shows promise for treating Niemann-Pick disease type C1
Por um escritor misterioso
Last updated 10 novembro 2024
NIH researchers demonstrated that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1.
TRIALS: A Fight for Children with Niemann-Pick Type C, a Fatal Genetic Disease
Niemann–Pick Disease Type C
Frontiers Emerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies
IJMS, Free Full-Text
Diagnostic workup and management of patients with suspected Niemann-Pick type C disease - Apostolos Papandreou, Paul Gissen, 2016
Family races to raise money for research no one will fund - The Boston Globe
IJMS, Free Full-Text
Like a tunnel for cholesterol': Scientists show how 'bad' cholesterol gets into cells
Niemann-Pick disease type C as a neurovisceral disease. Schematic
Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage - ScienceDirect
Models to study basic and applied aspects of lysosomal storage disorders - ScienceDirect
Recomendado para você
você pode gostar